Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are ...

Investing.com -- Genprex (NASDAQ:GNPX) stock surged 25% after the company announced that its research collaborators will present positive preclinical data on its Reqorsa® Gene Therapy for treating ...

Dr. J. Nicholas Bodor of Fox Chase Cancer Center explains possible risk factors, symptoms to watch for, and the importance of ...

Lung cancer affects up to 25% of non-smokers, so persistent symptoms and genetic testing are key for early detection and treatment. Dr. Ioana Bonta, adjunct clinical assistant professor at Morehouse ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

A lung cancer diagnosis can feel frightening. And when a family member is diagnosed, you might wonder about your own risk, prompting you to ask if lung cancer is hereditary. Smoking tobacco accounts ...

Lung cancer remains the leading cause of cancer-related death in the United States. The good news is that early detection ...

23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the Lung Cancer Genetics Study. Launched in 2024, ...

Smoking can cause lung cancer. But not all smokers get lung cancer, and about 25% of all lung cancer patients have never smoked, showing that some other factors beyond just smoking are at work. New ...

Medicover is proud to announce additional results from the ongoing DART clinical study from Oslo University Hospital. The study utilises Medicover Genetics' hybrid capture-based, tumour-agnostic MRD ...

Ten years ago, my husband Sergio was diagnosed with advanced lung cancer at age 65. He refused the only treatment offered to ...

People with advanced lung or skin cancer who were taking certain immunotherapy drugs lived substantially longer if they also ...